Replay
Replay is advancing a next-generation gene therapy platform designed for RDEB....
28 October, 2025
Archive
30 September, 2025
NanoCure
A medical grade nanoneedle bandage for topical COL7A1 gene therapy...
19 May, 2025
ELK-003
An opthalmic solution for the treatment of corneal abrasions associated with Epidermolysis Bullosa...
29 January, 2025
mRNA-based base editing
Evaluation of long-term effect on skin homeostasis and regeneration in a RDEB mouse model ...
27 January, 2025
Therapy for JEB Airway Disease
Towards cell and gene therapy for Junctional Epidermolysis Bullosa airway disease...
15 January, 2025
Nova Anchora
Development of NvA-011, a recombinant version of collagen VII for topical application in Dystrophic EB....
21 November, 2024
Base & Prime Editing for RDEB
The project aims to develop a strategy that could be used to treat a significant subset of RDEB patients carrying selected mutations....
28 February, 2024
Nonsense Tx
Nonsense Tx reading through disease causing nonsense codons...
13 December, 2023
PASTE gene therapy in DEB
PASTE-Mediated Superexon Replacement of COL7A1 as a Treatment for Dystrophic Epidermolysis Bullosa...
01 September, 2022
Editing of RDEB fibroblasts
Testing the in vivo efficacy of base and prime editing in primary fibroblasts and in a 3D skin model of dystrophic epidermolysis bullosa...